Exai Bio Inc. — Form D
Exai Bio Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-11. The offering totals $71.5M, of which $70.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-11
- Form: D
- Accession: 0001887123-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $71.5M
- Amount sold: $70.6M
- Remaining: $808K
- Investors: 21
- Date of first sale: 2021-09-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-461365
Issuer
- Name: Exai Bio Inc.
- CIK: 0001887123
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 3350 W. BAYSHORE ROAD, PALO ALTO, CA, 94303
- Phone: 000-000-0000
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Patrick A Arensdorf | Director | Palo Alto, CA |
| Hani A Goodarzi | Director | Palo Alto, CA |
| Alexander A Parker | Director | New York, NY |
| Michael A Pellini | Director | Los Altos, CA |
| Patrick A Arensdorf | Executive Officer | Palo Alto, CA |
More